To view this email as a web page, go here.
Message below is a paid advertisement. Content is provided by the sponsor.

888-608-2542

Finally, an FDA-approved transdermal for cats!

A survey of US veterinarians indicates that roughly 9 million cats present with weight loss/inappetence due to underlying conditions each year.^1-3 However, only 2 million of those cats are prescribed medication (compounded or human generic mirtazapine) to manage their weight loss.

Why? 74% of veterinarians indicated that the ease of administering a medication is one of the most important factors in selecting a medication for the management of weight loss in cats.¹

With Mirataz, veterinarians can confidently recommend an effective topically applied product for cats with unintended weight loss that may be associated with underlying disease.

To learn more about Mirataz, visit our website or call us at 888-608-2542.

Watch application video

Your friends at,
KindredBio

References: 1. 2017 Mirataz Pricing Research, Kynetec, September 2017 (n=204 U.S. small animal veterinarians). 2. Data on file Kindred Biosciences. 3. American Pet Products Association (APPA), 2017-2018 National Pet Owners Survey (n=22,202 respondents).

Mirataz is indicated for the management of weight loss in cats

Important Safety Information

Mirataz^® (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients or in cats treated with monomine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves to apply and wash hands after. Avoid contact with treated cat for 2 hours following application. The most common adverse reactions include application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting. For product label, including complete safety information click here.

Privacy Policy | Terms of Use | Unsubscribe